(FILES) In this file photo taken on August 13, 2020 Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida. (Photo by CHANDAN KHANNA / AFP)
Washington, United States — Moderna on Monday announced its experimental vaccine against COVID-19 was shown to be 94.5 percent effective based on early results from a clinical trial with more than 30,000 participants.
“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” said Stephane Bancel, Moderna’s CEO.
MOST READ
LATEST STORIES